MetaCap

AdaptHealth Corp. (AHCO)

NASDAQ: AHCOHealth CareMedical/Nursing ServicesUSD

7.20-0.05 (-0.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AHCO stock chart

Technical analysis

Key statistics

All statistics
Market cap
$982.98M
EPS (TTM)
-$3.23
52-week range
5.21 – 13.43
Day range
7.15 – 7.42
Volume / Avg
1.07M / 2.55M
Beta
—

52-week range

$5.21$13.43

AHCO stock today

Shares of AdaptHealth (AHCO) finished lower on Nov 20 at $7.20, a drop of 0.69% or $0.05 per share, versus the S&P 500's 3.70% decline. Trading was light, with 1.07M shares changing hands, about 42% of the average daily volume. Shares are 46.4% below their 52-week high of $13.43, set on May 4, 2026 and 38.2% above the 52-week low of $5.21, in the middle of the past year's range.

AHCO is down 27.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 24.9%. AdaptHealth has posted a net loss over the last twelve months (EPS of -$3.23), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About AdaptHealth

Company profile

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies.

Industry
Medical/Nursing Services
CEO
Ms. Suzanne M. Foster M.P.H.
Headquarters
Conshohocken, PA
Employees
10,900
IPO year
2018

Financial highlights

Full financials

In fiscal 2025, AdaptHealth generated $3.24 billion in revenue, down 0.5% from fiscal 2024, the first decline in the 8 years shown. AdaptHealth reported a net loss of $70.8 million, compared with net income of $90.4 million a year earlier. Gross margin was 18.8% (down from 20.9%) and operating margin 2.8%.

AdaptHealth annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.24B$3.26B$3.20B$2.97B$2.45B
Growth-0.49%+1.90%+7.73%+21.02%+132.35%
Net income$-70.79M$90.42M$-678.89M$69.32M$156.18M
EPS (diluted)$-0.52$0.61$-5.31$0.33$0.67

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$8.86+23.06%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $10.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$-1.13 vs —

AHCO news

All AHCO news

AdaptHealth peers

Health Care sector
AHCO peer companies
CompanyPrice% ChgMarket capCompare
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs AHCO
OMDAOmada Health Inc.11.87-5.04%$736.39Mvs AHCO
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs AHCO
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs AHCO
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs AHCO
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs AHCO
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs AHCO
SRTAStrata Critical Medical Inc. Class A4.56-5.59%$407.30Mvs AHCO

Indexes, lists and sector

AdaptHealth stock FAQ

What is AdaptHealth's stock price today?

AHCO last traded at $7.20 as of Nov 20, 4:00 PM EST, down 0.69% on the day. Prices are delayed at least 15 minutes.

Who is AdaptHealth's CEO?

Ms. Suzanne M. Foster M.P.H. is the chief executive officer of AdaptHealth Corp., which has about 10,900 employees.

What is the AHCO 52-week high?

The 52-week high for AHCO is $13.43 and the 52-week low is $5.21. The stock is currently 46.4% below its high.

Compare AHCO